Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/06/2021 26 5
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/05/2021 73 13
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/24/2020 36 38
Theaflavin Potential treatment - pre-clinical evidence Natural product Antiviral Dec/09/2020 2 0
Remdesivir Approved by FDA Experimental Antiviral Dec/02/2020 48 4
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Dec/01/2020 7 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Nov/26/2020 22 11
N-acetylcysteine Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Nov/18/2020 1 1
Anakinra  Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/18/2020 10 0
Interferon beta-1a Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/12/2020 2 1